Fairfield, Bush & Co. Abbott Laboratories Transaction History

Fairfield, Bush & Co.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $99,479 - $121,771	1,103 New	1,103 $121 Million
Q2 2023 Aug 15, 2023	BUY	$100.78 - $112.29 $111,160 - $123,855	1,103 New	1,103 $120 Million
Q1 2022 May 06, 2022	BUY	$114.02 - $139.04 $125,764 - $153,361	1,103 New	1,103 $131,000
Q2 2018 Aug 16, 2018	SELL	$57.57 - $63.54 $88,657 - $97,851	-1,540 Closed	0 $0
Q1 2018 May 09, 2018	BUY	$56.27 - $63.62 $86,655 - $97,974	1,540 New	1,540 $92,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Fairfield, Bush & Co., based on Form 13F filings with the SEC.

Stay updated on Fairfield, Bush & Co. with notifications on news.